Kohei Uemura

779 total citations
49 papers, 470 citations indexed

About

Kohei Uemura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kohei Uemura has authored 49 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Surgery. Recurrent topics in Kohei Uemura's work include Lung Cancer Treatments and Mutations (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Kohei Uemura is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Kohei Uemura collaborates with scholars based in Japan, Australia and United States. Kohei Uemura's co-authors include Kenzo Maehashi, Takashi Ikuta, T Sundaresan, Takaomi Kobayashi, Kohei Takeda, Tomoki Shimokawa, Toshihiro Fukui, Shuichiro Takanashi, Sunao Shoji and Hideo Yasunaga and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Kohei Uemura

42 papers receiving 455 citations

Peers

Countries citing papers authored by Kohei Uemura

Since Specialization

Citations

This map shows the geographic impact of Kohei Uemura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Uemura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Uemura more than expected).

Fields of papers citing papers by Kohei Uemura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Uemura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Uemura. The network helps show where Kohei Uemura may publish in the future.

Co-authorship network of co-authors of Kohei Uemura

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Uemura. A scholar is included among the top collaborators of Kohei Uemura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Uemura. Kohei Uemura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tetanus toxoid vaccination uptake by trauma patients in Japan: A retrospective cohort study using large administrative claims data 2025 ·Vaccine ·Sachiko Ono, Mikio Nakajima, Hayato Yamana, Nobuaki Michihata, Kohei Uemura, (unknown), (unknown)	0
2	Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience 2024 ·Prostate Cancer and Prostatic Diseases ·Sunao Shoji, (unknown), Shigeaki Ohno, Manabu Aoki, (unknown), (unknown), Satoshi Kuroda, (unknown), Nobuyuki Nakajima, Masanori Hasegawa, Yoshiaki Kawamura, Hiroshi Kajiwara, (unknown), Kohei Uemura, Terumitsu Hasebe, Takuma Tajiri	3
3	Physical Peculiarity of Two Sites in Human Promoters: Universality and Diverse Usage in Gene Function 2024 ·International Journal of Molecular Sciences ·Kohei Uemura, Takashi Ohyama	0
4	Real‐World Study of EGFR‐TKI Rechallenge With Another TKI After First‐Line Osimertinib Discontinuation in Patients With EGFR‐Mutated Non‐Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study 2024 ·Thoracic Cancer ·(unknown), Kazunari Tateishi, Kiyotaka Yoh, Kazuhiro Usui, Yukio Hosomi, Kazuma Kishi, Go Naka, Kageaki Watanabe, (unknown), Kohei Uemura, Hideo Kunitoh	0
5	Outcome of osimertinib-treated patients with epidermal growth factor receptor mutation-positive nonsmall cell lung cancer requiring dose reduction: a secondary analysis of the Reiwa study 2024 ·Japanese Journal of Clinical Oncology ·Nobuyasu Awano, (unknown), Kazuhiro Usui, Yukio Hosomi, Kazuma Kishi, Go Naka, Kageaki Watanabe, (unknown), Kohei Uemura, Hideo Kunitoh	1
6	Observational study of the efficacy and safety of first-line osimertinib and later treatments for uncommon epidermal growth factor receptor-activating mutation-positive advanced non-small cell lung cancer 2024 ·Japanese Journal of Clinical Oncology ·Tsuyoshi Hirata, Kageaki Watanabe, Yukio Hosomi, (unknown), Kazuhiro Usui, Kazuma Kishi, Go Naka, (unknown), Kohei Uemura, Hideo Kunitoh	1
7	Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study 2024 ·Respirology ·(unknown), Takehito Shukuya, Kohei Uemura, Takuo Hayashi, Toshihide Ueno, Shinji Kohsaka, Yoshihiro Masui, (unknown), (unknown), Tetsuhiko Asao, Yoichiro Mitsuishi, Naoko Shimada, Fumiyuki Takahashi, Kazuya Takamochi, (unknown), Kazuhisa Takahashi, Kuniaki Seyama	2
8	The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study) 2024 ·JTO Clinical and Research Reports ·Kageaki Watanabe, Yukio Hosomi, (unknown), Yoshiro Nakahara, Yoko Tsukita, Hirotaka Matsumoto, (unknown), Yasuhito Fujisaka, (unknown), (unknown), Kazuhiro Usui, Kazuma Kishi, Go Naka, (unknown), Kohei Uemura, Hideo Kunitoh	4
9	Effectiveness of vaccination on influenza-related critical illnesses in the elderly population 2023 ·Journal of Infection and Chemotherapy ·Shotaro Aso, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga	2
10	Distinctive physical properties of DNA shared by RNA polymerase II gene promoters and 5′-flanking regions of tRNA genes 2023 ·The Journal of Biochemistry ·Kohei Uemura, Takashi Ohyama	3
11	Association between the antiadhesion membrane and small bowel obstruction after open gastrectomy: A supplemental analysis of the randomized controlled JCOG1001 trial 2023 ·Annals of Gastroenterological Surgery ·(unknown), Masanori Terashima, Junki Mizusawa, Kohei Uemura, Yukinori Kurokawa, Shuji Takiguchi, Yuichiro� Doki, Jun Hihara, Hiroshi Imamura, Akinori Takagane, Seiji Ito, Takaki Yoshikawa, Takeshi Sano, Mitsuru Sasako	3
12	A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial) 2023 ·Liver Cancer ·Akihiko Ichida, (unknown), Etsuro Hatano, Susumu Eguchi, Akio Saiura, Hiroaki Nagano, (unknown), Masaji Hashimoto, Nobuyuki Takemura, Kojiro Taura, Yoshihiro Sakamoto, Yu Takahashi, Yasuji Seyama, Yasuharu Sasaki, Kohei Uemura, Norihiro Kokudo, (unknown)	15
13	Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study 2022 ·BMJ Open ·Kageaki Watanabe, Kiyotaka Yoh, Yukio Hosomi, Kazuhiro Usui, Go Naka, Kazuma Kishi, Kohei Uemura, Yasuo Ohashi, Hideo Kunitoh	5
14	Association of change in health-related quality of life and treatment discontinuation in metastatic breast cancer: a post hoc, exploratory analysis of two randomized clinical trials 2022 ·Supportive Care in Cancer ·Takuya Kawahara, Takayuki Iwamoto, (unknown), (unknown), Kohei Uemura, Yukari Uemura, Hirofumi Mukai, Yuichiro Kikawa, Naruto Taira	5
15	Surgical aortic valve replacement provides better left ventricular mass regression than transcatheter aortic valve replacement in patients with small aortic annulus 2022 ·General Thoracic and Cardiovascular Surgery ·(unknown), (unknown), Kohei Uemura, Tomoki Shimokawa, Toshihiro Fukui	7
16	Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes 2020 ·International Journal of Clinical Oncology ·Sunao Shoji, Shinichiro Hiraiwa, Kohei Uemura, Masahiro Nitta, Masanori Hasegawa, Yoshiaki Kawamura, (unknown), Terumitsu Hasebe, Takuma Tajiri, Akira Miyajima	34
17	Preoperative renal malperfusion is an independent predictor for acute kidney injury and operative death but not associated with late mortality after surgery for acute type A aortic dissection 2020 ·European Journal of Cardio-Thoracic Surgery ·(unknown), Toshihiro Fukui, Kohei Uemura, Shuichiro Takanashi, Tomoki Shimokawa	25
18	The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancer 2018 ·Lung Cancer ·Kentaro Ito, Satoru Miura, Tadashi Sakaguchi, Kenta Murotani, Nobuyuki Horita, Hiroaki Akamatsu, Kohei Uemura, Satoshi Morita, Nobuyuki Yamamoto	9
19	Hybrid molecular imprinted membranes having selectivity and separation behavior to targeted indole derivatives 2007 ·Analytica Chimica Acta ·Kohei Takeda, Kohei Uemura, Takaomi Kobayashi	23
20	Sudden death of a patient with primary hypereosinophilia, colon tumours, and pulmonary emboli 2004 ·Journal of Clinical Pathology ·Kohei Uemura, Makoto Nakajima, Naoko Yamauchi, Masashi Fukayama, Kenichi Yoshida	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact